FRAZIER MANAGEMENT LLC
SEATTLE, WA · CIK 1032165 · 13F filing filed 2022-02-08
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityFRAZIER MANAGEMENT, L.L.C. (US)
- Others nearbySeattle, WA
As an employer
US visa salary filings
- Filings FY20251
- Median salary offered$125,000
- Middle half$125,000 – $125,000
- Job titles1
| Job title | Filings | Median |
|---|---|---|
| Associate, Investment AnalystSeattle, WA | 1 | $125,000 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Frazier Management LLC.
$1.3bn
reported value
+3.9% vs Q3 2021
43positions
55.9%in top 10
6 new
12 added
2 reduced
4 sold out
vs Q3 2021
Holdings, Q4 2021
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $174.9m13.47% | Unchanged |
| PHATHOM PHARMACEUTICALS INC PHAT | $114.6m8.82% | Unchanged |
| IMAGO BIOSCIENCES INC COM | $70.4m5.42% | Unchanged |
| SYNDAX PHARMACEUTICALS INC SNDX | $60.7m4.67% | Added +1.6m |
| GRITSTONE BIO INC GRTS | $60.0m4.62% | Unchanged |
| MIRUM PHARMACEUTICALS INC MIRM | $56.9m4.38% | Unchanged |
| VAXCYTE INC PCVX | $54.9m4.23% | Unchanged |
| KRYSTAL BIOTECH INC KRYS | $53.9m4.15% | Unchanged |
| PARDES BIOSCIENCES INC COM | $40.2m3.10% | New |
| CRINETICS PHARMACEUTICALS IN CRNX | $39.3m3.03% | Added +533.0k |
| CHINOOK THERAPEUTICS INC ADRO | $38.7m2.98% | Added +700.0k |
| BICYCLE THERAPEUTICS PLC BCYC | $33.8m2.60% | Added +112.4k |
| IOVANCE BIOTHERAPEUTICS INC IOVA | $33.4m2.57% | Reduced -926.7k |
| TARSUS PHARMACEUTICALS INC TARS | $31.9m2.45% | Unchanged |
| PASSAGE BIO INC COM | $31.8m2.45% | Unchanged |
| ANAPTYSBIO INC ANAB | $31.3m2.41% | Unchanged |
| IVERIC BIO INC OPHT | $30.7m2.37% | Unchanged |
| VIRIDIAN THERAPEUTICS INC VRDN | $29.8m2.29% | Unchanged |
| SIERRA ONCOLOGY INC COM NEW | $27.5m2.12% | Added +460.2k |
| SUTRO BIOPHARMA INC COM | $26.4m2.04% | Added +307.8k |
| ALPINE IMMUNE SCIENCES INC NVLS | $24.7m1.90% | Added +13.1k |
| SILENCE THERAPEUTICS PLC SLN | $21.2m1.63% | New |
| AUTOLUS THERAPEUTICS PLC AUTL | $19.4m1.50% | Added +216.2k |
| MERUS N V MRUS | $17.8m1.37% | New |
| REPLIMUNE GROUP INC REPL | $17.6m1.36% | Added +158.9k |
| TYRA BIOSCIENCES INC TYRA | $17.6m1.35% | Unchanged |
| KALVISTA PHARMACEUTICALS INC KALV | $17.3m1.33% | Added +1.1m |
| TRICIDA INC TCDA | $17.1m1.31% | New |
| COGENT BIOSCIENCES INC COGT | $15.2m1.17% | New |
| FRAZIER LIFESCIENCES ACQU CO UNIT 12/09/2025 | $14.9m1.15% | Unchanged |
| ARVINAS INC ARVN | $13.5m1.04% | New |
| GRACELL BIOTECHNOLOGIES INC SPONSORED ADS | $10.0m0.77% | Added +803.3k |
| ESSA PHARMA INC EPI | $7.7m0.59% | Added +185.1k |
| REGENXBIO INC RGNX | $7.7m0.59% | Unchanged |
| AVADEL PHARMACEUTICALS PLC SPONSORED ADR | $7.7m0.59% | Unchanged |
| ACLARIS THERAPEUTICS INC ACRS | $5.9m0.46% | Unchanged |
| MOLECULAR TEMPLATES INC COM | $5.4m0.41% | Unchanged |
| APTINYX INC COM | $5.0m0.39% | Unchanged |
| IMMUNOVANT INC IMVT | $5.0m0.38% | Unchanged |
| SCHOLAR ROCK HLDG CORP SRRK | $3.9m0.30% | Unchanged |
| EPIZYME INC EPZM | $1.8m0.14% | Unchanged |
| ALLENA PHARMACEUTICALS ALNA | $978.0k0.08% | Reduced -1.7m |
| NABRIVA THERAPEUTICS PLC SHS | $255.0k0.02% | Unchanged |
Sold out since Q3 2021
| Security | Value then |
|---|---|
| TRILLIUM THERAPEUTICS INC TR | $55.0m3.1m shares |
| BELLUS HEALTH INC NEW BLU | $2.6m433.2k shares |
| GALERA THERAPEUTICS INC | $2.0m241.0k shares |
| FREELINE THERAPEUTICS HLDGS | $1.9m550.0k shares |